Northwest Biotherapeutics (OTCMKTS:NWBO) Stock Crosses Below Two Hundred Day Moving Average of $0.75
Northwest Biotherapeutics (OTCMKTS:NWBO) Stock Crosses Below Two Hundred Day Moving Average of $0.75
Shares of Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO – Get Rating) passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.75 and traded as low as $0.61. Northwest Biotherapeutics shares last traded at $0.64, with a volume of 7,043,841 shares changing hands.
西北生物治療學公司（OTCMKTS：NWBO-獲得評分）在周二交易期間低於 200 天移動平均線的股票通過。該股票的 200 天移動平均線為 0.75 美元，交易價格低至 0.61 美元。西北生物治療學股票最後交易價為 0.64 美元，交易量為 7,043,841 股。
Northwest Biotherapeutics Stock Performance
西北生物治療股票表現
The stock has a market cap of $686.45 million, a price-to-earnings ratio of -6.35 and a beta of -0.03. The company has a 50-day moving average of $0.68 and a 200-day moving average of $0.75.
該股的市值為 68645 萬美元，股價與收益比為 -6.35，測試值為 -0.03。該公司擁有 50 天移動平均線 0.68 美元，200 天移動平均線為 0.75 美元。
About Northwest Biotherapeutics
關於西北生物治療學
(Get Rating)
(取得評分)
Northwest Biotherapeutics, Inc is a biotechnology company, which engages in the development of personalized immune therapies for cancer. It offers DCVax technology platform, which uses activated dendritic cells to mobilize a patient's own immune system to attack their cancer. The company was founded by Alton L.
西北生物治療學公司是一家生物技術公司，致力於癌症個性化免疫療法的開發。它提供 DCVax 技術平台，該平台使用活性樹突細胞調動患者自身的免疫系統來攻擊癌症。該公司由奧爾頓 L.
Featured Stories
特色故事
- Get a free copy of the StockNews.com research report on Northwest Biotherapeutics (NWBO)
- On Holding AG Sprints Higher on Margin Expansion and Guidance
- Price Growth & Yield: For That Magical Combo, Leave the U.S.
- Game-Changing News For Tesla Investors
- DOW New Hghs Coming Sooner Than Later
- The Tide Is Turning For Harley-Davidson
- 免費索取西北生物治療研究報告
- 關於控股股份公司在利潤擴張和指導方面的更高衝刺
- 價格增長和收益率：對於那個神奇的組合，離開美國
- Tesla 投資者的改變遊戲規則
- 陶氏指數新 HGHS 比以後更早推出
- 潮汐正在轉向哈雷戴維森
Receive News & Ratings for Northwest Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northwest Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
接收西北生物治療日報的新聞和評分 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件通訊接收有關西北生物治療及相關公司的最新新聞和分析師評級的簡要每日摘要。
譯文內容由第三人軟體翻譯。